Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 23,705 | 24,232 | 25,697 | 20,674 | 23,118 |
| Operating Income | -23,705 | -24,232 | -25,697 | -20,674 | -23,118 |
| Other Income | 3,072 | 3,668 | 3,823 | 3,257 | 1,925 |
| Pre-tax Income | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 |
| Net Income Continuous | -20,633 | -20,564 | -21,874 | -17,417 | -21,193 |
| Net Income | $-20,633 | $-20,564 | $-21,874 | $-17,417 | $-21,193 |
| EPS Basic Total Ops | -0.60 | -0.61 | -0.65 | -0.70 | -6.62 |
| EPS Basic Continuous Ops | -0.60 | -0.61 | -0.65 | -0.70 | -6.63 |
| EPS Diluted Total Ops | -0.60 | -0.61 | -0.65 | -0.70 | -6.62 |
| EPS Diluted Continuous Ops | -0.60 | -0.61 | -0.65 | -0.70 | -6.63 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.61 | -0.65 | N/A | N/A |
| EBITDA(a) | $-23,705 | $-24,232 | $-25,697 | $-20,674 | $-23,118 |